Negative Regulation of Human Fibrinogen Gene Expression by Peroxisome Proliferator-activated Receptor α Agonists via Inhibition of CCAAT Box/Enhancer-binding Protein β
Open Access
- 1 September 2001
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (36) , 33471-33477
- https://doi.org/10.1074/jbc.m102839200
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1Journal of Biological Chemistry, 1999
- Functional Antagonism between CCAAT/Enhancer Binding Protein-α and Peroxisome Proliferator-activated Receptor-γ on the Leptin PromoterPublished by Elsevier ,1997
- The PPARα–leukotriene B4 pathway to inflammation controlNature, 1996
- Characterization of the 5′-Flanking Region of the Gene for the α Chain of Human FibrinogenPublished by Elsevier ,1995
- Characterization of the 5′-Flanking Region of the Gene for the γChain of Human FibrinogenJournal of Biological Chemistry, 1995
- Characterization of the IL-6 Responsive Elements in the γ Fibrinogen Gene PromoterJournal of Biological Chemistry, 1995
- Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates.Journal of Clinical Investigation, 1995
- Tumor necrosis factor-induced reversal of adipocytic phenotype of 3T3-L1 cells is preceded by a loss of nuclear CCAAT/enhancer binding protein (C/EBP).Journal of Clinical Investigation, 1992
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984